X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17) 17
index medicus (14) 14
immunohistochemistry (7) 7
oncology (7) 7
genetics (6) 6
microsatellite instability (6) 6
mutation (6) 6
colorectal cancer (5) 5
colorectal neoplasms - genetics (5) 5
pathology (5) 5
cancer (4) 4
cancer research (4) 4
female (4) 4
genetic aspects (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
research article (4) 4
tumors (4) 4
aged (3) 3
biomarkers (3) 3
carcinoma (3) 3
colon-cancer (3) 3
colorectal neoplasms - immunology (3) 3
colorectal neoplasms - pathology (3) 3
dna (3) 3
expression (3) 3
flow cytometry (3) 3
gene expression (3) 3
gene expression regulation, neoplastic (3) 3
genetics & heredity (3) 3
immunotherapy (3) 3
immunotherapy - methods (3) 3
male (3) 3
medicin och hälsovetenskap (3) 3
medicine, research & experimental (3) 3
middle aged (3) 3
mismatch repair (3) 3
monoclonal-antibodies (3) 3
neoplasms - immunology (3) 3
proteins - genetics (3) 3
research (3) 3
t-cells (3) 3
adenomatous polyposis coli - genetics (2) 2
adult (2) 2
alleles (2) 2
antigen-processing machinery (2) 2
article (2) 2
biochemistry & molecular biology (2) 2
breast (2) 2
carcinomas (2) 2
care and treatment (2) 2
checkpoint blockade (2) 2
chromosome 1 (2) 2
chromosome 1q (2) 2
class-switch recombination (2) 2
cohort studies (2) 2
colorectal neoplasms, hereditary nonpolyposis - genetics (2) 2
colorectal polyps (2) 2
colorectal-cancer (2) 2
ctla-4 blockade (2) 2
cytotoxicity (2) 2
digestive system diseases (2) 2
dna - metabolism (2) 2
dna glycosylases - genetics (2) 2
dna methylation (2) 2
dna repair (2) 2
down-regulation (2) 2
erratum (2) 2
exome sequencing (2) 2
flow-cytometry (2) 2
genetic predisposition to disease (2) 2
genetics & genomics (2) 2
genome (2) 2
hereditary colorectal cancer (2) 2
hla antigens - analysis (2) 2
homozygosity mapping (2) 2
immune checkpoint (2) 2
immunoglobulin class switching (2) 2
immunology (2) 2
immunotherapy - adverse effects (2) 2
immunotherapy - trends (2) 2
instability (2) 2
linkage analysis (2) 2
loss of heterozygosity (2) 2
lymphocytes, tumor-infiltrating - immunology (2) 2
medical and health sciences (2) 2
metastases (2) 2
mhc class-i (2) 2
mia3 (2) 2
molecular targeted therapy (2) 2
neoplasms (2) 2
neoplasms - genetics (2) 2
patients (2) 2
pd-1 blockade (2) 2
ploidies (2) 2
polyposis (2) 2
repressor proteins - genetics (2) 2
sequence analysis, dna (2) 2
t-lymphocytes - immunology (2) 2
tissue (2) 2
tissue array analysis (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Experimental Medicine, ISSN 0022-1007, 2013, Volume 210, Issue 9, pp. 1729 - 1742
Journal Article
Journal Article
Laboratory Investigation, ISSN 0023-6837, 01/2018, Volume 98, Issue 1, pp. 41 - 50
Sarcomas are a rare group of tumors of mesenchymal origin. Metastatic sarcomas are often difficult to treat and unresponsive to standard radio- and... 
TUMOR-INFILTRATING LYMPHOCYTES | MEDICINE, RESEARCH & EXPERIMENTAL | DNA MISMATCH REPAIR | CTLA-4 BLOCKADE | MDM2 GENE AMPLIFICATION | GENOMIC LANDSCAPE | PD-L1 EXPRESSION | MICROSATELLITE INSTABILITY | POOR-PROGNOSIS | MUTATIONAL LANDSCAPE | PATHOLOGY | T-CELLS | Sarcoma - secondary | Drugs, Investigational - adverse effects | Drugs, Investigational - pharmacology | Sarcoma - immunology | Humans | Drugs, Investigational - therapeutic use | Drug Resistance, Neoplasm | Antibodies, Blocking - pharmacology | Antineoplastic Agents - therapeutic use | Chemotaxis, Leukocyte - drug effects | T-Lymphocytes - metabolism | Antineoplastic Agents - adverse effects | T-Lymphocytes - drug effects | Immunotherapy - trends | Biomarkers, Tumor - metabolism | Biomedical Research - methods | Antineoplastic Agents - pharmacology | Costimulatory and Inhibitory T-Cell Receptors - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | DNA Mismatch Repair - drug effects | Biomedical Research - trends | Sarcoma - drug therapy | Immunotherapy - adverse effects | Biomarkers, Tumor - blood | Sarcoma - metabolism | Animals | Antibodies, Blocking - adverse effects | Lymphocyte Activation - drug effects | Costimulatory and Inhibitory T-Cell Receptors - metabolism | Antibodies, Blocking - therapeutic use | T-Lymphocytes - immunology | Medical research | Mesenchyme | Melanoma | Clinical trials | Lung carcinoma | Metastasis | Patients | Survival | Metastases | Chemotherapy | Inhibitors | Immune checkpoint | PD-L1 protein | Biomarkers | Infiltration | Clear cell-type renal cell carcinoma | Tumors
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 25, pp. 38180 - 38190
Journal Article
Journal Article
The Journal of Experimental Medicine, ISSN 0022-1007, 11/2013, Volume 210, Issue 12, pp. 2503 - 2513
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 12/2011, Volume 1246, Issue 1, pp. 50 - 63
Journal Article